DGAP-News: Epigenomics AG / Key word(s): Conference 2016-11-14 / 17:48 Press release Epigenomics AG to participate in investor conferences Berlin (Germany) and Germantown, MD (U.S.A.), November 14, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) today announced that Greg Hamilton, Chief Executive Officer, will participate in the following investor conferences: – Canaccord Genuity Medical Technologies & Diagnostics Forum, Thursday November 17, 2016, New York, Westin New York Grand Central, Presentation: 10:00 am (EST) – German Equity Forum 2016, Tuesday, November 22, 2016, Frankfurt, Sheraton Frankfurt Airport Hotel, Presentation: 5:00 PM (CET) – goetzpartners Interdisciplinary Oncology Insight Symposium, November 29, 2016, London, Le Meridien Piccadilly, Panel discussion: 2:00 PM (GMT) About Epigenomics For more information, visit www.epigenomics.com. Contact Epigenomics AG Peter Vogt https://www.epigenomics.com
2016-11-14 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English | |
Company: | Epigenomics AG | |
Geneststraße 5 | ||
10829 Berlin | ||
Germany | ||
Phone: | +49 30 24345-0 | |
Fax: | +49 30 24345-555 | |
E-mail: | ir@epigenomics.com | |
Internet: | www.epigenomics.com | |
ISIN: | DE000A11QW50 | |
WKN: | A11QW5 | |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange | |
End of News | DGAP News Service |